Analysts At Numis Securities Reiterated Hikma Pharmaceuticals (LON:HIK) As Add

Today analysts at Numis Securities reiterated Hikma Pharmaceuticals’s (LON:HIK) shares as ‘Add’ in a report released to investors.

According to Numis Securitiess price target of 2350 on the company’s stock this indicates the broker now believes there is an increase of 17.44% from Hikma Pharmaceuticals’s current price of 2001.


In the last year Hikma Pharmaceuticals’s stock price has increased by 3.99% from 1924.24 to 2001.

The number of Hikma Pharmaceuticals shares in issue is 240,000,000 which have a current share price of 2001 bringing Hikma Pharmaceuticals’s market capitalisation to 4.80B GBp.

The 52 week high of shares in Hikma Pharmaceuticals is 2703 while the 52 week low for the company’s shares is 1575. The businesses 50 day moving average is 2071.27 and its 200 day moving average is 1919.06.

Error parsing: Query returned empty response

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for with's FREE daily email newsletter.

Leave A Response